Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory Cytokines and Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure
- 29 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 99 (7) , 758-766
- https://doi.org/10.1161/01.res.0000244092.95152.86
Abstract
Blocking brain mineralocorticoid receptors (MRs) reduces the high circulating levels of tumor necrosis factor (TNF)-α in heart failure (HF) rats. TNF-α and other proinflammatory cytokines activate neurons in the paraventricular nucleus (PVN) of hypothalamus, including corticotropin-releasing hormone (CRH) neurons, by inducing cyclooxygenase (COX)-2 activity and synthesis of prostaglandin E 2 by perivascular cells of the cerebral vasculature. We tested the hypothesis that systemic treatment with a MR antagonist would reduce hypothalamic COX-2 expression and PVN neuronal activation in HF rats. Rats underwent coronary ligation to induce HF, confirmed by echocardiography, or sham surgery, followed by 6 weeks treatment with eplerenone (30 mg/kg per day, orally) or vehicle (drinking water). Eplerenone-treated HF rats had lower plasma TNF-α, interleukin (IL)-1β and IL-6, less COX-2 staining of small blood vessels penetrating PVN, fewer PVN neurons expressing Fra-like activity (indicating chronic neuronal activation), and fewer PVN neurons staining for TNF-α, IL-1β, and CRH than vehicle-treated HF rats. COX-2 and CRH protein expression in hypothalamus were 1.7- and 1.9-fold higher, respectively, in HF+vehicle versus sham+vehicle rats; these increases were attenuated (26% and 25%, respectively) in HF+eplerenone rats. Eplerenone-treated HF rats had less prostaglandin E 2 in cerebrospinal fluid, lower plasma norepinephrine levels, lower left ventricular end-diastolic pressure, and lower right ventricle/body weight and lung/body weight ratios, but no improvement in left ventricular function. Treatment of HF rats with anticytokine agents, etanercept or pentoxifylline, produced very similar results. This study reveals a previously unrecognized effect of MR antagonism to minimize cytokine-induced central neural excitation in rats with HF.Keywords
This publication has 35 references indexed in Scilit:
- Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarctionHeart, 2005
- Prostaglandin E2 Mediates Cellular Effects of Interleukin-1beta on Parvocellular Neurones in the Paraventricular Nucleus of the HypothalamusJournal of Neuroendocrinology, 2005
- Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarctionCardiovascular Research, 2005
- Effects of central oxytocin receptor blockade on water and saline intake, mean arterial pressure, and c-Fos expression in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2003
- Heart failure and the brain: new perspectivesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2003
- Guiding principles for research involving animals and human beingsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
- Prostaglandins as inflammatory messengers across the blood-brain barrierJournal of Molecular Medicine, 2002
- Cytokines in Heart Failure: Pathogenetic Mechanisms and Potential TreatmentProceedings of the Association of American Physicians, 1999
- Evidence for an Intramedullary Prostaglandin-Dependent Mechanism in the Activation of Stress-Related Neuroendocrine Circuitry by Intravenous Interleukin-1Journal of Neuroscience, 1997
- Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifyllineInternational Journal of Immunopharmacology, 1996